KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 26th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Apr 12, 2016 $10.55 $11.09 $10.32 $10.81 241 455
Apr 11, 2016 $10.80 $11.04 $10.44 $10.54 267 497
Apr 08, 2016 $11.06 $11.06 $10.45 $10.63 238 547
Apr 07, 2016 $11.10 $11.50 $10.75 $10.80 283 271
Apr 06, 2016 $10.49 $11.32 $10.41 $11.19 411 280
Apr 05, 2016 $10.08 $10.95 $10.08 $10.41 415 940
Apr 04, 2016 $10.07 $10.69 $10.04 $10.11 330 252
Apr 01, 2016 $9.25 $10.12 $9.07 $10.02 338 898
Mar 31, 2016 $8.66 $9.48 $8.66 $9.35 379 154
Mar 30, 2016 $8.70 $9.24 $8.53 $8.79 342 860
Mar 29, 2016 $7.82 $8.65 $7.57 $8.64 277 700
Mar 28, 2016 $8.12 $8.26 $7.68 $7.91 190 100
Mar 24, 2016 $7.69 $8.66 $7.51 $8.07 342 400
Mar 23, 2016 $8.82 $9.01 $7.68 $7.76 478 500
Mar 22, 2016 $8.40 $9.15 $8.40 $8.82 309 000
Mar 21, 2016 $8.14 $8.92 $8.14 $8.67 407 100
Mar 18, 2016 $7.73 $8.17 $7.65 $8.14 538 900
Mar 17, 2016 $7.75 $7.94 $7.24 $7.71 728 600
Mar 16, 2016 $8.06 $8.40 $7.68 $7.79 523 400
Mar 15, 2016 $9.50 $9.77 $8.01 $8.09 1 468 200
Mar 14, 2016 $9.54 $10.30 $9.50 $10.03 249 400
Mar 11, 2016 $9.25 $9.64 $9.15 $9.62 211 200
Mar 10, 2016 $9.64 $10.19 $8.95 $9.14 336 500
Mar 09, 2016 $10.02 $10.08 $9.08 $9.58 252 500
Mar 08, 2016 $11.05 $11.24 $9.93 $9.93 395 800
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT